Please read these articles
http://boards.fool.co.uk/Message.asp?mid=7842473

http://www.advfn.com/cmn/fbb/thread.php3?id=3982666

http://www.medisys-group.com/Prelims_5_061202-1.pdf'

http://www.safetysyringesplus.com/info.htm

This has massive potential from products other than FUTURA which if it takes off will be the iceing on the cake.Let me give you the highlights from this Mays interims;

Financial Highlights

Financial performance improved significantly:

* Turnover increased by 9% to #20.1 million (2002: #18.4 million)

* Product sales increased by 25% on a constant US dollar exchange rate basis

* Earnings before interest, tax, depreciation and amortisation was #0.3
million (2002: EBITDA loss of #7.0 million, before exceptional items, as
restated)

* Gross margin 37% (2002: 33%)

* Selling, distribution and administration costs reduced to #4.8 million
(2002: #7.4 million before exceptional items)

* Profit before amortisation and research and development expenditure
#2.6 million (2002: loss of #0.8 million before exceptional items)

* Research and development expenditure #3.0 million (2002: #7.1 million,
as restated)

* Operating loss #1.3 million (2002: #9.2 million, before exceptional
items, as restated)

* Loss before tax #1.6 million (2002: #9.2 million, before exceptional
items, as restated)

* Loss per share 0.58p (2002: 2.58p, before exceptional items, as
restated)

Product Highlights

* Sales of existing products in line with expectations

- Sales of Assure range increased to #6.9 million (2002: #5.6 million)

- QuickTek sales to mail order market segment #2.6 million

- Sales of Futura Safety Scalpel #1.0 million in period

- Sales of Advance system #0.5 million in period

* Futura Safety Syringe and Flight disposable blood glucose monitoring
system remain on track for mid-2003 market launch

* Development of Spear capillary fill bio-sensor strip proceeding to
schedule.

Pretty impressive eh !!

Now since this we have had;

FDA approval for Hypogaurd

http://www.advfn.com/p.php?pid=nmona&cb=1064066532&article=4778825&symbol=LSE%3AMDY

Futura passing final quality tests with Smiths

http://www.advfn.com/p.php?pid=nmona&cb=1064066532&article=5023328&symbol=LSE%3AMDY

A partnership with Walmart for Flight

http://www.advfn.com/p.php?pid=nmona&cb=1064066532&article=5194692&symbol=LSE%3AMDY

Launch of Spear

http://www.advfn.com/p.php?pid=nmona&cb=1064066532&article=5250424&symbol=LSE%3AMDY

Medisys "buy"

Monday, September 29, 2003 8:28:27 AM ET
Dryden Financial

LONDON, September 29 (New Ratings) Analyst I Broadhurst of Dryden Financial issues a "buy" rating on Medisys (MDY.L).

2003 New Ratings

Now this looks to me a company growing rapidly.The more I look into MDY the more confident I become of the potential rewards.These will not be instantaneous but will come over a period of time.Look at the turnaround in those figures posted above.Now that was in a recession.

http://www.charles-stanley.co.uk/content/SMI_oct03.pdf (see page 4)

http://www.research.reuters.co.uk/Research/Earnings.asp?ticker=MDY.L&country=GB&mxid=100068815&companyName=MEDISYS+PLC&sym=RE
VERY IMPORTANT MESSAGE TO ALL BUYERS/HOLDERS - PLEASE LISTEN

http://www.wallstreetreporter.com/profiles/Medisys.html

Medisys PLC Chief Executive Officer Talks to the Wall Street Transcript

http://biz.yahoo.com/bw/040113/135638_1.html

can anyone help me with regards to medisys plc has i have been out of the country and dont know wants been happening with this stock????????//

llew it dropped after they termianted the distribution agreement with Smiths after derogatory comments from the Smiths CEO.THings are comming back on line and the results were very very good.They will now be marketing the Syringe themselves until a new distribution partner has been found.

Seems to be a consistant buyer of large lumps.

L2 strengthed at the close 2 vs 1

thanks very much happy1?lets hope you are right as i have brought some more of this stock?

10S Gone through 50.Higher lows.If it breaks 200.Well?


Worth a punt.

I certainly think it is.

This is now starting to get interesting again

ANY STOCK THAT TRADES HUGE VOLUME AT HIGHER PRICES SIGNALS THE DISTRIBUTION PHASE."

When there was less volume, the price was lower. Professionals were
accumulating. After the price runs, the volume increases. The professionals bought low and sold high. The amateurs bought high (and will soon enough sell low). In older books about market manipulation and stock promotion, which I've recently studied, the mark-up price referred to THREE times higher than the floor. The floor is the launch pad for the stock. For example, if one looks at the stock price and finds a steady flat line on the stock's chart of around 10p , then that range is the FLOOR. Basically, the mark-up phase can go as high as the market manipulator is capable of taking it. From my observations, a good mark-up should be able to run about five to ten times higher than the floor, with six to seven being common. The market manipulator will do everything in his power to keep you OUT OF THE STOCK until the share price has been marked up by at least two-three times, sometimes resorting to "shaking you out" until after he has accumulated enough shares. Once the mark-up has begun, the stock chart will show you one or more spikes in the volume -- all at much higher prices (marked up by the manipulator, of course).

I think we all have to agree that these market manipulators have a damn sight more information than we do. There is nothing to say that they know maybe of impending news and hence that scenario works. What we have seen is a floor established and people wanting to get their money out as other opportunities come along. This is all well and good and I respect that. Some however are keen to accumulate stock at this level as they know that if the management do actually deliver there will be a very strong and sharp rise in the share price.


ADVFN seems to attract traders wanting a 10-20%+ return on their money in a few days. It does not, to some extent, attract investors who are prepared to lock away their shares for a year or two and hopefully reap much better rewards. Go back to the likes of YOO,AHT or CS. and think what mountain of cash you would be sitting on now had you bought and held !

Everyone slags certain stocks off and deservedly MDY has attracted alot of attention due to the recent departure from Smiths.Time is moving closer to the timescales discussed by the MDY management and it is now time to see if they can actually deliver on their promises this time round.

Nomura have given fair value at 20p without Flight or Futura. Now I am quite happy to sit this one out and wait for the long awaited iceing on the cake wether it is delivered in a month or three as I know when we get it we will all be very very happy investors.

Very interesting development on BBC website.Could hold serious potential for MDY.

Very interesting development on BBC website.Could hold serious potential for MDY.
http://news.bbc.co.uk/1/hi/health/3505777.stm

MDY had big sells today can anyone let me know why?has i have not heard anything for a while?????????

pc4900074200 - 26 Feb'04 - 17:32 - 3768 of 3770


Just reading the 2003 Annual reports & accounts.
On page 42 I see that Medisys and Smiths have
agreed to meet and a forum is provisionally set
for March. They will attempt to resolve their claims.

More good news on the way!!

pc

Interesting !!!

This share is an absolute disaster area, I sold my holding last April at 13.87, and look at the price now! " More good news on the way" what are you talking about Happy? Another 12 months waiting for something positive to happen?

Suggest you read the last set of results in more detail then !

1.EBITDA POSITIVE

2.LAUNCH OF FLIGHT TO WALMART

3.LAUNCH OF FUTURA SYRINGE

The price represents the current sentiment which when it changes will be relected.

Medisys is it on the way up on this news:-Medisys, Smiths confirm termination of Futura Safety Syringe distribution deal
AFX


LONDON (AFX) - Medisys PLC and Smiths Group PLC said their dispute concerning distribution of the Futura Safety Syringe has been resolved to the satisfaction of both parties and the Distributorship Agreement between them has been terminated.

Medisys confirms that it continues to market its Futura Safety Syringe product in the US and other markets.

newsdesk@afxnews.com

slm/

OR IS IT ON THE WAY DOWN ON THIS NEWS

Medisys says Hypoguard, 3 others named in complaint for patent infringement
AFX


LONDON (AFX) - Medisys PLC said Hypoguard, its diagnostics division, has been named as one of four defendants in a complaint for patent infringement made by Roche Diagnostics Corp in the US.

The other named defendants are Apex Biotechnology Corp, Medline Industries, Inc and Home Diagnostics Inc.

The complaint, in the Indianapolis Division of the US District Court, alleges that the use and sale of the Assure family of blood glucose monitoring products infringe two patents owned by Roche.

The Assure products are made and supplied to Hypoguard by Apex under a supply and distribution agreement. This agreement includes an indemnity, given by Apex to Hypoguard, for liability arising from the Assure products infringing the intellectual property of a third party, Medisys said. Apex confirmed that it will stand behind such indemnity in relation to Roche's complaint, Medisys added.

Hypoguard said it is investigating the validity of the patents and will respond to the complaint once it has completed its probe.

newsdesk@afxnews.com

jc

No matter which one you choose, today saw a 7.3% rise with trades of 18 or so million 12.5million buys to 8.2 million sells. This company would appear to be in the wars and not only needs an injection but some protective headgear and body armour to avoid being too hurt from the head,body, heady blows. One thing after another seems to halt its recouperation. It would seem that it is a cheap stock at this time, just a little get well note from the injured party would let us know that it is on the road to recovery and would be well appreciated by its 'family' of shareholders. Good luck DYOR.

Happy get a life and put your money in to something else.

Scottie SIT there's a good BOY !

SOme people dont fully understand the potential returns on offer here !

Scottie, if you're not into this, why waste your time (and ours) posting useless statements?